Study of repeated administration of fenbufen in patients with chronic rheumatic disorders and renal impairment.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000378:metabolism* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010654:Phenylbutyrates; D011422:Propionates / Q000378:metabolism* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D010654:Phenylbutyrates; D011422:Propionates; C010725:fenbufen